https://www.worldpharmaceuticals.net/news/abbvie-and-evolveimmune-partner-to-develop-advanced-cancer-therapies/ 2024-11-01T08:03:51+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-35.webp https://www.worldpharmaceuticals.net/news/merck-reports-33-decline-in-q3-2024-net-income/ 2024-11-01T12:18:59+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-38.webp https://www.worldpharmaceuticals.net/news/accenture-invests-in-1910-genetics-for-ai-based-drug-discovery/ 2024-11-01T13:14:34+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/laboratory-8895975_1920.webp https://www.worldpharmaceuticals.net/news/teva-fined-e462-6m-by-ec-for-delaying-copaxone-competition/ 2024-11-01T13:40:55+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/tingey-injury-law-firm-veNb0DDegzE-unsplash.webp https://www.worldpharmaceuticals.net/news/uk-announces-50m-investment-to-boost-medicine-supply-for-nhs/ 2024-11-04T09:33:58+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-48.webp https://www.worldpharmaceuticals.net/news/novo-nordisks-wegovy-shows-promise-in-essence-trial/ 2024-11-04T12:34:17+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-51.webp https://www.worldpharmaceuticals.net/news/tevas-tev-749-yields-positive-results-in-phase-3-schizophrenia-trial/ 2024-11-04T12:47:20+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/brain-4961452_1920.webp https://www.worldpharmaceuticals.net/news/oncoinvent-reports-positive-18-month-data-on-radspherin-for-colorectal-cancer/ 2024-11-04T13:25:04+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/D85_6864_hands-1320x869-1.webp https://www.worldpharmaceuticals.net/news/bighat-licenses-synaffixs-adc-technology-platform/ 2024-11-05T10:19:02+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-1.webp https://www.worldpharmaceuticals.net/news/journey-medicals-emrosi-secures-fda-nod-for-rosacea-treatment/ 2024-11-05T12:33:10+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/psoriasis-5996424_1920.webp https://www.worldpharmaceuticals.net/news/vertex-pharma-reports-q3-2024-net-income-of-1-04bn/ 2024-11-05T13:12:22+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-4.webp https://www.worldpharmaceuticals.net/news/vitrian-invests-in-amplifybios-biomanufacturing-facility-in-ohio/ 2024-11-06T09:17:52+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-21.webp https://www.worldpharmaceuticals.net/news/fdb-announces-first-phase-expansion-of-biologics-facility-in-hillerod/ 2024-11-06T12:12:00+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-24.webp https://www.worldpharmaceuticals.net/news/canada-approves-gsks-arexvy-for-rsv-prevention-in-adults-aged-50-to-59/ 2024-11-06T12:56:31+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/Scientist-holding-lab-syringe.webp https://www.worldpharmaceuticals.net/uncategorized/intra-cellulars-caplyta-shows-efficacy-in-late-stage-schizophrenia-trial/ 2024-11-06T13:15:30+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/milad-fakurian-58Z17lnVS4U-unsplash.webp https://www.worldpharmaceuticals.net/news/teva-pharmaceutical-reports-q3-2024-net-loss-of-437m/ 2024-11-07T08:15:50+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-28.webp https://www.worldpharmaceuticals.net/news/plus-therapeutics-spectronrx-enter-manufacturing-partnership/ 2024-11-07T11:35:55+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-31.webp https://www.worldpharmaceuticals.net/news/avid-bioservices-to-go-private-in-1-1bn-deal-with-gho-and-ampersand/ 2024-11-07T12:01:01+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/toon-lambrechts-dvYKZyVLC9c-unsplash.webp https://www.worldpharmaceuticals.net/news/eu-approves-dupixent-for-treating-eosinophilic-esophagitis-in-young-children/ 2024-11-07T12:16:42+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/Dupixent_Pen_and_Packaging.webp https://www.worldpharmaceuticals.net/news/fda-proposes-ban-on-oral-phenylephrine-in-cold-and-flu-drugs/ 2024-11-08T11:31:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/anxieties-342449_1920.webp https://www.worldpharmaceuticals.net/news/radella-reports-positive-phase-1a-results-for-md-18-obesity-treatment/ 2024-11-08T12:42:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/measuring-tape-4590164_1920.webp https://www.worldpharmaceuticals.net/news/santen-arctic-vision-partner-for-arvn001/ 2024-11-08T12:53:33+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-38-1.webp https://www.worldpharmaceuticals.net/news/viatris-reports-q3-2024-net-income-of-95m/ 2024-11-08T13:13:25+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-35-1.webp https://www.worldpharmaceuticals.net/news/kalaris-to-merge-with-allovir-to-become-publicly-traded-company/ 2024-11-11T08:38:14+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-53.webp https://www.worldpharmaceuticals.net/news/astrazeneca-amgens-tezspire-shows-promise-in-trial/ 2024-11-11T10:32:07+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-55.webp https://www.worldpharmaceuticals.net/news/alteogen-partners-with-daiichi-sankyo-to-develop-subcutaneous-version-of-enhertu/ 2024-11-11T11:53:21+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/laboratory-3827740_1920.webp https://www.worldpharmaceuticals.net/news/jj-seeks-regulatory-nod-for-darzalex-faspros-new-indication-in-us-and-eu/ 2024-11-11T12:23:34+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/jandJ-1.webp https://www.worldpharmaceuticals.net/news/swedish-researchers-develop-new-antibody-for-cancer-treatment/ 2024-11-12T08:21:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-65.webp https://www.worldpharmaceuticals.net/news/alk-licenses-rights-to-ars-pharmas-allergy-drug-neffy-outside-us/ 2024-11-12T11:49:11+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-68.webp https://www.worldpharmaceuticals.net/news/emraclidine-fails-to-meet-primary-endpoint-in-schizophrenia-trials/ 2024-11-12T12:38:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/robina-weermeijer-3KGF9R_0oHs-unsplash.webp https://www.worldpharmaceuticals.net/news/zai-lab-and-argenx-get-approval-for-vyvgart-hytrulo-in-china-for-cidp/ 2024-11-12T13:10:26+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/neuron-7091663_1920.webp https://www.worldpharmaceuticals.net/news/astrazeneca-reports-4-rise-in-q3-2024-net-income-to-1-43bn/ 2024-11-13T08:30:23+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-80.webp https://www.worldpharmaceuticals.net/news/mutated-ras-genes-to-promote-tumour-growth/ 2024-11-13T11:45:07+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-83.webp https://www.worldpharmaceuticals.net/news/schrodinger-and-novartis-ink-drug-development-deal-worth-up-to-2-5bn/ 2024-11-13T12:34:25+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/trnava-university-Lr_MKzNGhUU-unsplash.webp https://www.worldpharmaceuticals.net/news/pfizer-mulls-sale-of-hospital-drugs-business-amid-investor-pressure/ 2024-11-13T13:36:38+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/Logo_Outside.webp https://www.worldpharmaceuticals.net/news/biontech-to-acquire-chinese-cancer-drugmaker-biotheus-for-800m/ 2024-11-14T12:13:28+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-90.webp https://www.worldpharmaceuticals.net/news/tae-life-sciences-and-stella-pharma-ink-bnct-deal-for-us-europe/ 2024-11-14T12:48:04+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/stem-5004507_1920.webp https://www.worldpharmaceuticals.net/news/lillys-tirzepatide-reduces-type-2-diabetes-risk-shows-weight-loss/ 2024-11-14T12:54:45+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/pngwithsrgbspace.webp https://www.worldpharmaceuticals.net/news/ptc-therapeutics-gets-fda-nod-for-kebilidi-to-treat-aadc-deficiency/ 2024-11-14T13:06:52+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-93.webp https://www.worldpharmaceuticals.net/news/merck-licenses-lanovas-investigational-drug-lm-299/ 2024-11-15T07:45:44+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-96.webp https://www.worldpharmaceuticals.net/news/azurity-secures-fda-approval-for-danziten/ 2024-11-15T10:29:30+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-99.webp https://www.worldpharmaceuticals.net/news/halozyme-offers-e11-per-share-to-acquire-evotec-for-e2bn/ 2024-11-15T13:27:29+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/laptop-3196481_1920.webp https://www.worldpharmaceuticals.net/news/bristol-myers-squibb-hit-with-renewed-6-7bn-charge-over-delayed-cancer-drug-approvals/ 2024-11-15T13:41:11+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/02-LVL-Exterior-Sign-101520-media.webp https://www.worldpharmaceuticals.net/news/fda-accepts-dupixent-resubmission-for-review-in-chronic-spontaneous-urticaria-treatment/ 2024-11-18T07:30:27+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/Dupixent_Pen_and_Packaging-1.webp https://www.worldpharmaceuticals.net/news/syndax-and-royalty-pharma-sign-350m-royalty-funding-agreement-for-niktimvo/ 2024-11-18T11:57:36+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/julia-koblitz-6u8SbtZ0q1c-unsplash.webp https://www.worldpharmaceuticals.net/news/syndax-secures-fda-approval-for-revuforj-to-treat-r-r-acute-leukaemia/ 2024-11-18T12:04:48+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/anirudh-UiwUtEqROEs-unsplash.webp https://www.worldpharmaceuticals.net/news/bms-gets-positive-chmp-opinion-for-opdivo-in-mcrc-treatment/ 2024-11-18T12:28:41+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/syringe-5904302_1920.webp https://www.worldpharmaceuticals.net/news/sandoz-secures-ec-marketing-nod-for-eylea-biosimilar-afqlir/ 2024-11-18T13:07:38+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/eye-5248678_1920.webp https://www.worldpharmaceuticals.net/news/aclaris-to-license-biosions-two-biologics-assets-for-up-to-940m/ 2024-11-19T09:15:44+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-108.webp https://www.worldpharmaceuticals.net/news/alkeus-gets-fda-rare-designations-for-gildeuretinol/ 2024-11-19T11:49:39+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-112.webp https://www.worldpharmaceuticals.net/news/jjs-icotrokinra-meets-co-primary-endpoints-in-phase-3-plaque-psoriasis-trial/ 2024-11-19T12:52:52+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/nsey-benajah-RBzm131cMHk-unsplash.webp https://www.worldpharmaceuticals.net/news/lillys-lpa-targeting-candidate-muvalaplin-meets-primary-endpoint-in-phase-2-trial/ 2024-11-19T13:24:08+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/man-1846050_1920.webp https://www.worldpharmaceuticals.net/news/bayer-to-develop-and-market-cytokinetics-aficamten-in-japan/ 2024-11-20T07:56:56+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-134.webp https://www.worldpharmaceuticals.net/news/sangamo-gets-fda-ind-approval-for-st-503/ 2024-11-20T11:31:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-137.webp https://www.worldpharmaceuticals.net/news/pharmanovia-licenses-lindis-catumaxomab-for-malignant-ascites/ 2024-11-20T13:07:49+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/mitosis-3876669_1920.webp https://www.worldpharmaceuticals.net/news/mercks-phase-3-trial-of-sc-pembrolizumab-in-nsclc-meets-primary-pk-endpoints/ 2024-11-20T13:24:55+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/Headquarters_Rahway-Site-Entrance_3_HI.webp https://www.worldpharmaceuticals.net/news/pfizer-gets-ec-approval-for-hympavzi/ 2024-11-21T08:41:37+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-1-1.webp https://www.worldpharmaceuticals.net/news/ucb-gets-fda-approval-for-bimzelx-to-treat-hidradenitis-suppurativa/ 2024-11-21T12:13:42+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-4-1.webp https://www.worldpharmaceuticals.net/news/exscientia-merges-with-recursion-to-create-drug-discovery-platform/ 2024-11-21T12:24:55+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/handshake-6796386_1920.webp https://www.worldpharmaceuticals.net/news/sage-discontinues-dalzanemdor-after-phase-2-hd-study-fails/ 2024-11-21T13:16:18+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/doctor-1228627_1920.webp https://www.worldpharmaceuticals.net/news/novartis-acquires-gene-therapy-maker-kate-therapeutics/ 2024-11-22T08:39:32+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-8.webp https://www.worldpharmaceuticals.net/news/zai-lab-partners-with-pfizer-to-commercialise-xacduro-in-china/ 2024-11-22T11:16:39+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-11.webp https://www.worldpharmaceuticals.net/news/carvykti-approved-in-canada-for-second-line-myeloma-treatment/ 2024-11-22T12:42:31+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/download-1.webp https://www.worldpharmaceuticals.net/news/jazz-secures-fda-nod-for-ziihera-to-treat-her2-positive-btc/ 2024-11-22T12:54:50+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/Jazz_Pharmaceuticals_plc_Approved_Ziihera.webp https://www.worldpharmaceuticals.net/news/merck-secures-chinas-nmpa-approval-for-welireg-vhl-tumours/ 2024-11-25T08:44:51+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-26.webp https://www.worldpharmaceuticals.net/news/bridgebio-gets-fda-nod-for-attruby-to-treat-attr-cm-patients/ 2024-11-25T11:49:57+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/11/New-Project-29.webp